JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on November 16, 2006; DOI: 10.1124/jpet.106.111443


0022-3565/07/3202-907-916$20.00
JPET 320:907-916, 2007
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.106.111443v1
320/2/907    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Azam, M. A.
Right arrow Articles by Takuwa, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Azam, M. A.
Right arrow Articles by Takuwa, Y.

CARDIOVASCULAR

Ca2+-Independent, Inhibitory Effects of Cyclic Adenosine 5'-Monophosphate on Ca2+ Regulation of Phosphoinositide 3-Kinase C2{alpha}, Rho, and Myosin Phosphatase in Vascular Smooth Muscle

Mohammed Ali Azam, Kazuaki Yoshioka, Shinsuke Ohkura, Noriko Takuwa, Naotoshi Sugimoto, Koichi Sato, and Yoh Takuwa

Department of Physiology, Kanazawa University Graduate School of Medicine, Kanazawa, Japan (M.A.A., K.Y., N.S., Y.T.); Department of Veterinary Pharmacology, Faculty of Agriculture, Yamaguchi University, Yamaguchi, Japan (S.O., K.S.); and Department of Health and Medical Sciences, Ishikawa Prefectural Nursing University, Kahoku, Japan (N.T.)

We have recently demonstrated in vascular smooth muscle (VSM) that membrane depolarization by high KCl induces Ca2+-dependent Rho activation and myosin phosphatase (MLCP) inhibition (Ca2+-induced Ca2+-sensitization) through the mechanisms involving phosphorylation of myosin-targeting protein 1 (MYPT1) and 17-kDa protein kinase C (PKC)-potentiated inhibitory protein of PP1 (CPI-17). In the present study, we investigated whether and how cAMP affected Ca2+-dependent MLCP inhibition by examining the effects of forskolin, cell-permeable dibutyryl cAMP (dbcAMP), and isoproterenol. Forskolin, but not its inactive analog 1,9-dideoxyforskolin, inhibited KCl-induced contraction and the 20-kDa myosin light chain (MLC) phosphorylation without inhibiting Ca2+ mobilization in rabbit aortic VSM. dbcAMP mimicked these forskolin effects. We recently suggested that Ca2+-mediated Rho activation is dependent on class II {alpha}-isoform of phosphoinositide 3-kinase (PI3K-C2{alpha}). Forskolin inhibited KCl-induced stimulation of PI3K-C2{alpha} activity. KCl-induced membrane depolarization stimulated Rho in a manner dependent on a PI3K but not PKC and stimulated phosphorylation of MYPT1 at Thr850 and CPI-17 at Thr38 in manners dependent on both PI3K and Rhokinase, but not PKC. Forskolin, dbcAMP, and isoproterenol inhibited KCl-induced Rho activation and phosphorylation of MYPT1 and CPI-17. Consistent with these data, forskolin, isoproterenol, a PI3K inhibitor, or a Rho kinase inhibitor, but not a PKC inhibitor, abolished KCl-induced diphosphorylation of MLC. These observations indicate that cAMP inhibits Ca2+-mediated activation of the MLCP-regulating signaling pathway comprising PI3K-C2{alpha}, Rho, and Rho kinase in a manner independent of Ca2+ and point to the novel mechanism of the cAMP actions in the regulation of vascular smooth muscle contraction.


Received July 23, 2006; accepted November 15, 2006.

Address correspondence to: Dr. Yoh Takuwa, Department of Physiology, Kanazawa University Graduate School of Medicine, 13-1 Takara-machi, Kanazawa, Ishikawa 920-8640, Japan. E-mail:ytakuwa{at}med.kanazawa-u.ac.jp




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
Y. M. Seok, I. Baek, Y.-H. Kim, Y.-S. Jeong, I.-J. Lee, D. H. Shin, Y. H. Hwang, and I. K. Kim
Isoflavone Attenuates Vascular Contraction through Inhibition of the RhoA/Rho-Kinase Signaling Pathway
J. Pharmacol. Exp. Ther., September 1, 2008; 326(3): 991 - 998.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
D. Schaafsma, K. D. McNeill, G. L. Stelmack, R. Gosens, H. A. Baarsma, B. G. J. Dekkers, E. Frohwerk, J.-M. Penninks, P. Sharma, K. M. Ens, et al.
Insulin increases the expression of contractile phenotypic markers in airway smooth muscle
Am J Physiol Cell Physiol, July 1, 2007; 293(1): C429 - C439.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics.